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(Evans et al., 1993; Hatahet et al., 1994). Its removal in
human cells is initiated by a glycosylase/AP lyase activ-
ity closely related to E. coli endonuclease III, or Nth
(Aspinwall et al., 1997). In contrast, 8-oxoG is a premuta-
genic lesion that mispairs with A, generating GC to TA
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cises A inserted opposite 8-oxoG by DNA polymerases,
and MutT eliminates 8-oxoGTP from the pool of DNA
precursors. Mammalian homologs of all these activitiesSummary
have been identified. In human cells, hOGG1 encodes
a glycosylase/AP lyase functionally equivalent to FpgAnalysis of transcription-coupled repair (TCR) of oxi-
(Radicella et al., 1997; RoldaÂ n-Arjona et al., 1997; Rosen-dative lesions here reveals strand-specific removal of
quist et al., 1997).8-oxo-guanine (8-oxoG) and thymine glycol both in
Consistent with an essential role for BER in repairnormal human cells and xeroderma pigmentosum (XP)
of endogenous damage, embryonic lethality in mice iscells defective in nucleotide excision repair. In con-
caused by gene knockout of proteins required for latertrast, Cockayne syndrome (CS) cells including CS-B,
steps in BER, including AP endonuclease, DNA polymer-XP-B/CS, XP-D/CS, and XP-G/CS not only lack TCR
ase b, and XRCC1 (Wilson and Thompson, 1997). How-but cannot remove 8-oxoG in a transcribed sequence,
ever, loss of individual initiating enzymes, e.g., OGG1,despite its proficient repair when not transcribed. The
has relatively little effect, suggesting overlapping activi-XP-G/CS defect uniquely slows lesion removal in non-
ties (Klungland et al., 1999b). No naturally occurring hu-transcribed sequences. Defective TCR leads to a mu-
man mutations affecting only BER have been identified.tation frequency at 8-oxoG of 30%±40% compared to
Genetic defects in the human XPA through XPG genesthe normal 1%±4%. Surprisingly, unrepaired 8-oxoG
that inactivate NER result in the hereditary disease xero-blocks transcription by RNA polymerase II. These data
derma pigmentosum (XP), characterized by extreme sunimply that TCR is required for polymerase release to
sensitivity and proneness to UV-induced skin cancerallow repair and that CS results from defects in TCR
(reviewed in Thompson, 1998). A second sun-sensitiveof oxidative lesions.
disorder, Cockayne syndrome (CS), is both clinically and
genetically distinct from XP. It most often arises fromIntroduction
mutations in the CSA or CSB genes required for prefer-
ential removal of UV-induced lesions in template strandsOxidative damage to cellular genomes is implicated in a
of genes transcribed by RNA polymerase II (RNAP II) by avariety of disease states. It arises from attack by reactive
transcription-coupled repair (TCR) process, the detailedoxygen species (ROS) generated by a variety of means,
mechanism of which has remained elusive (reviewedincluding cellular metabolism and exposure to environ-
in Hanawalt, 1994; van Gool et al., 1997b; Thompson,mental agents such as ionizing radiation. Oxidatively
1998).damaged bases are primarily corrected by a specialized
Unlike XP, CS is characterized by small size at birthbase excision repair (BER) process initiated by a dual
followed by severe postnatal developmental failure andfunction DNA glycosylase that releases the altered base
early death (Nance and Berry, 1992). The clinical appear-concomitant with incision of the DNA chain by an AP
ance of CS in a few patients due to mutations in thelyase activity of the same enzyme. BER is distinct from
XPB, XPD, and XPG genes required for NER was initiallythe nucleotide excision repair (NER) pathway that re-
surprising. XPB and XPD are the helicase componentsmoves helix-distorting DNA lesions as an oligonucleo-
of basal transcription factor TFIIH required for transcrip-tide (for review of both see Friedberg et al., 1995; Lindahl
tion initiation by RNAP II. The role of TFIIH in NER in-et al., 1997; Lindahl and Wood, 1999). Important base
volves DNA unwinding around the lesion to allow inci-damages induced by ROS include thymine glycol (Tg)
sion by two structure-specific endonucleases (Evans etand 8-oxoguanine (8-oxoG, or GO). Tg is a lethal lesion
al., 1997a, 1997b). XPG makes the initial incision 39 tothat blocks both DNA and RNA polymerases in vitro
the lesion and is also required nonenzymatically for
subsequent 59 incision by the ERCC1/XPF heterodimer§ To whom correspondence should be addressed (e-mail: pkcooper@
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CNRS-CEA, 92265 Fontenay-aux-Roses, France. 3) are those that severely truncate the protein, whereas
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Figure 1. Strand-Specific Repair in a Restriction Fragment Containing the Human Metallothionein IA Gene after Exposure of Human Fibroblasts
to X Irradiation (10 Gy)
Repair was measured by an immunological assay that detects incorporation of BrUra in repair patches. Restricted DNA was reacted with an
antibody to BrUra and total repair was assessed by the amount of DNA bound. Equal amounts of DNA from the antibody-bound ªbº and free
ªfº fractions were separated by electrophoresis, transferred to a membrane, and hybridized with RNA probes for the metallothionein (MT)
gene family. Repair in the transcribed (TS) and nontranscribed strands (NTS) of MTIA, on a 10 kb EcoRI fragment, was determined from
intensity of hybridization multiplied by the proportion of DNA in the bound or free fraction.
(A) Repair in the following primary fibroblast strains: GM38 from a normal individual; two sibling XP-B/CS patients, GM13025 (squares) and
GM13026 (triangles); two XP-D patients, GM434 (squares) and GM3615 (triangles); and two XP-D/CS patients, XP8BR (squares) and GM3248
(triangles). Closed symbols are TS, open symbols are NTS, and X is total DNA. In most cases, data points are the average of two independent
determinations; error bars (SEM) were within the size of the symbols and are not shown.
(B) Repair in SV40-transformed fibroblasts: VA13 lung fibroblasts from a normal individual (squares) and XP12RO-SV fibroblasts from an XP-A
patient. TS, closed symbols; NTS, open symbols; total, X.
(C) Autoradiograms from representative experiments.
conservative single amino acid substitutions that elimi- generated oxidative damage may underlie the clinical
appearance of CS was suggested by the fact that thisnate NER but produce full-length protein (XP-G class 1)
result in XP only (Nouspikel et al., 1997). Similarly, XP-A process is defective in XP-G/CS as well as CS-B but
not in XP-G class 1 mutant cells (Cooper et al., 1997).patients lacking NER due to defects in damage recogni-
tion do not exhibit CS. Thus, the distinct and far more If this is so, then cells from all CS patients irrespective
of their particular genetic defect should lack TCR ofsevere symptoms of CS compared to XP are difficult to
reconcile with the idea that CS arises from defective oxidative lesions. This prediction is tested in the present
study by examination of cells with mutations in XPB andTCR if TCR is a subpathway of NER.
The observations that ionizing radiation damage is XPD. As for XP-G, there are several classes of XP-D
patients, most of which have only XP but with a rarepreferentially repaired in normal human cells by TCR
and that both this and strand-selective removal of Tg class represented by two patients also having CS
(Thompson, 1998). XP-B patients are extremely rare,require CSA and CSB but not NER raised the possibility
that BER of oxidative damage may be targeted to presumably reflecting the essential role of XPB in tran-
scription initiation (Tirode et al., 1999), and all three ofblocked transcription (Leadon and Cooper, 1993; Coo-
per et al., 1997). That defective TCR of endogenously the known patients have CS (Thompson, 1998).
Transcription-Coupled Repair and CS
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Table 1. Primary and Transformed Human Cell Strains/Lines Used
Cell Strain/Line Complementation Group; Phenotype Source
SV40-Transformed Lines
MRC5V1 Normal C. Arlett
VA13 Normal ATCC
XP12RO-SV XP-A D. Bootsma
XP4PA-SV XP-C A. Sarasin
XP8CAC-SV XP-C A. Sarasin
XP14BR-SV XP-C C. Arlett (as primary strain)*
XP6BE-SV XP-D ATCC
XP125LO-SV XP-G C. Arlett (as primary strain)*
XP2BI-SV XP-G class 2 B. Klein
XP3BR-SV XP-G class 2 B. Klein
XP2BI-pBK2 XP-G class 2, G418R P. Cooper
XP3BR-pBK6 XP-G class 2, G418R P. Cooper
XP2BI-pXPG1 XP-G cl. 2, corrected P. Cooper
XP3BR-pXPG1 XP-G cl. 2, corrected P. Cooper
XP3BR-pXPG3 XP-G cl. 2, corrected P. Cooper
CS1AN-SV CS-B C. Arlett
XP-CS-2-SV XP-D/CS A. Sarasin
XPCS1LV-SV XP-G/CS Coriell (as primary strain)*
XPCS2BA-SV XP-B/CS Kleijer (as primary strain)*
Primary Cell Strains
GM38 Normal Coriell
AS198 Normal A. Sarasin
XP125LO XP-G (class 1) C. Arlett
GM3021 (XP2BI) XP-G (class 2) Coriell
GM3616 (XP3BR) XP-G (class 2) Coriell
GM13371 (XPCS1LV) XP-G/CS Coriell
GM434 (XP3NE) XP-D Coriell
GM3615 (XP1BR) XP-D Coriell
XP8BR XP-D/CS A. R. Lehmann
GM3248 (XP-CS-2) XP-D/CS Coriell
GM13025 (XPCS1BA) XP-B/CS Coriell
GM13026 (XPCS2BA) XP-B/CS Coriell
GM739 (CS1AN) CS-B Coriell
* Transfection was carried out using the pLAS-wt plasmid carrying the TAg of SV40 as previously described (Daya-Grosjean et al., 1987).
Results (data not shown). This is further supported by normal
repair after X irradiation in SV40-transformed XP-A cells
(Figure 1B), consistent with previous results for primaryTCR of Oxidative DNA Damage in Cells
from Patients with XP-B and XP-D cells from a different XP-A patient (Cooper et al., 1997).
The TCR defect in XP-D/CS and XP-B/CS cells in-Repair of ionizing radiation damage in an active gene
was compared for cells from XP-D patients with XP only cludes inability to preferentially remove Tg from TS as
shown by studies of H2O2-treated cells using an antibodyand from XP-D/CS and XP-B/CS patients in order to
determine the generality of an association of the clinical specific for Tg, whereas XP-D cells were normal in this
regard (Figure 2A). Normal removal of Tg from the ge-appearance of CS with defective TCR. Cell strains used
are listed in Table 1. Cells from two different XP-D patients nome overall in these and in SV40-transformed XP-A
cells after X irradiation was confirmed by a quantitativewere proficient in TCR of this damage, with repair of the
transcribed strand (TS) of the active metallothionein IA enzyme-linked immunosorbent assay (Figure 2C), con-
sistent with lack of involvement of NER. We conclude(MTIA) gene occurring faster than in the nontranscribed
strand (NTS) and at the same rapid rate as in cells from that TCR of Tg but not its global genome repair requires
the TFIIH subunits XPB and XPD. This is in contrast toa normal individual (Figure 1A). In contrast, cells from
two XP-D/CS patients and the two XP-B/CS siblings all the requirement for XPG for efficient global Tg removal
as well as TCR (Cooper et al., 1997; Figure 2). Onlylack TCR, although repair in the genome overall was the
same as in normal cells (ªTotalº in Figure 1A). The assay certain mutations in XPD, those that confer CS, affect
this preferential repair.used detects the repair patch itself and thus provides
information concerning repair of all lesions induced by
ionizing radiation, most of which are removed by BER. Mutagenesis at 8-oxoG in Normal and Mutant
Human FibroblastsThe differential loss of TCR in XP-D/CS compared to XP-D
cells together with normal total repair in both suggests Whether 8-oxoG is among the oxidative lesions prefer-
entially repaired by TCR is of interest because of its highlack of significant involvement of NER in either TCR or
global repair of X-ray damage, since both cell types miscoding frequency. We addressed this question using
a single 8-oxoG paired with C in a shuttle vector (Figureare NER-defective and unable to remove UV-induced
cyclobutane pyrimidine dimers (CPDs) in either strand 3) transfected into human cells (Le Page et al., 1998). A
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Figure 2. Removal of Thymine Glycol from a
Restriction Fragment Containing MTIA after
Exposure of Human Fibroblasts to H2O2 and
from the Genome Overall after X Irradiation
Strand-specific repair after H2O2 treatment
was analyzed as in Figure 1 except that the
DNA was reacted with a monoclonal antibody
that recognizes thymine glycol (Tg) in DNA.
The fraction of fragments containing Tg
(bound by anti-Tg) immediately after treat-
ment was set equal to 100%. Global (genome
overall) removal of Tg after X irradiation was
determined by an enzyme-linked immuno-
sorbent assay using the same anti-Tg an-
tibody.
(A) Tg removal from the 10 kb EcoRI fragment
containing MTIA after H2O2 treatment to give
approximately 1 Tg per 10 kb in diploid fibro-
blasts: GM3615 (XP-D); XP8BR (XP-D/CS); or
GM13025 (XP-B/CS). TS (transcribed strand),
filled symbols; NTS (nontranscribed strand),
open symbols; Total DNA, X. The dotted lines
represent previously determined rates of re-
moval from TS and NTS of normal cells, with
error bars (SEM) indicated (not visible in most
cases as they are within the size of the sym-
bols). The dashed line in the middle and right
panels represents the previously determined
rate of removal in either strand of XP-G/CS
cells.
(B) Autoradiograms representative of those
from which the data of (A) were derived. ªbº,
antibody bound; ªfº, free DNA not bound by
anti-Tg.
(C) Rate of Tg removal from the genome overall after 10 Gy X-rays in normal cells, primary fibroblasts from CS patients with mutations in
XPB or XPD, and SV40-transformed cells from an XP-A patient. Data for XP-D/CS are averages of results from two different patients, and for
normal cells are averages of values from GM38 diploid cells and VA13 SV40-transformed cells, as these did not differ significantly. Only one
error bar (SEM) is visible. The value for the Tg content of the DNA from all cell strains immediately after irradiation (approximately 1 Tg per
million bases) was averaged and set equal to 100%. The dashed line represents values previously determined for XP-G/CS cells.
sequence containing a unique 8-oxoG was inserted into In all cell lines, the vast majority of the mutations were
G to T transversions at the site of the lesion (Table 2).the 39-untranslated region of SV40 large T antigen (TAg)
in the strand transcribed from the SV40 early promoter, The very high frequency of mutation at 8-oxoG when
transcribed in the four types of CS cell lines correlatesdeletion of which eliminates transcription of TAg and of
the sequence containing the lesion. When the lesion is with inability to perform TCR of Tg (Figure 2 and Cooper
et al., 1997).in the corresponding position on the opposite strand,
its transcription occurs from the SV40 late promoter and The correlation between defective repair of oxidative
damage and the clinical appearance of CS is furthercan be eliminated by its deletion (Figure 3B). Use of
these alternative constructs thus allowed comparison supported by a third phenotypic class of XP-G patients.
These have both severe clinical XP and characteristicsof cellular processing of 8-oxoG with and without tran-
scription. The shuttle vector replicates autonomously in reminiscent of CS, although for the originally described
members of this class, XP3BR and XP2BI, no clinicalhuman cells transfected with SV40 TAg (Le Page et al.,
1998), allowing determination of the frequency of muta- diagnosis of CS was made (Vermeulen et al., 1993). Cells
from these patients of intermediate clinical presentationgenesis at 8-oxoG in human cells.
The mutation frequency induced by 8-oxoG on the (XP-G class 2) are intermediate with respect to TCR of
X-ray damage and of Tg (P. K. C. and S. A. L., unpublishedlate strand without transcription was only 1%±4% in all
human cell lines tested (Figure 4C). When the lesion was data). Importantly, these cells also had intermediate mu-
tation frequencies of about 20% (Figure 4B). They havein the same sequence but on the opposite strand and
transcribed with TAg, the same low level of mutagenesis been complemented with respect to UV survival, CPD
removal, and TCR of oxidative damage by stable trans-was observed for normal and NER-defective cell lines,
including an XP-A mutant, three different XP-C mutants, fection with wild-type XPG cDNA (P. K. C. and S. A. L.,
unpublished data). Several independent complementedand XP-D and XP-G (class 1) mutant lines. However, in
cell lines from a CS-B patient and all three types of XP/ clones had mutation frequencies at 8-oxoG averaging
3%, similar to the low level in normal cells and statisti-CS patients, the mutation frequency rose to 30%±40%
(Figure 4A and Table 2). This difference in mutation fre- cally different from the parental cell lines (P , 0.001),
whereas the same cells transfected by the vector alonequency between classical XP and XP/CS or CS cells
was highly significant using a chi-square test (P , 0.001). had the original intermediate mutation frequency (Figure
Transcription-Coupled Repair and CS
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4B and Table 2). Thus, mutagenesis at 8-oxoG in TS in
XP-G class 2 and, by extension, XP-G/CS (class 3) cells
is directly attributable to loss of an XPG function.
Rate of Removal of 8-oxoG is Dependent
on Its Transcription
The high mutation frequency in CS cells suggests a
corresponding defect in removal of 8-oxoG. To test this,
we constructed nonreplicating vectors with the SV40
origin deleted (Figure 3). These were transfected into
various human cell strains and recovered after 2±72 hr
for analysis of persistence of the lesion by replication
in repair-defective bacteria. In normal and XP-G class
1 cells, repair of 8-oxoG when transcribed was complete
by 12 hr, corresponding closely to the time of replication
of this plasmid (Le Page et al., 1998) and in agreement
with the observed low mutation frequency. However,
XP-G/CS and CS-B cells were blocked for this repair,
with no detectable removal even after 3 days (Figure
5A). The intermediate mutation frequency in class 2
XP-G cells was mirrored by intermediate repair, with
greatly reduced removal of 8-oxoG from 2±12 hr and no
further repair thereafter (Figure 5A). In contrast, when the
8-oxoG on either strand was in an NTS, it was removed
efficiently in all cells (Figure 5B, data not shown). Thus,
differences in mutagenesis at 8-oxoG that were depen-
dent on its transcriptional state were reflected by parallel
differences in its TCR.
Although 8-oxoG when not transcribed was eventually
repaired completely in all cells, examination of the early
kinetics revealed significant differences between the
mutant and normal strains (Figure 5C). Repair in the first
6 hr was much faster in normal and class 1 XP-G cells
when the lesion was transcribed. This establishes that
8-oxoG, like Tg, is preferentially repaired by TCR but
not NER. The removal of 8-oxoG from NTS was identical
in normal and CS-B cells, in contrast to a reported defi-
ciency in incision at 8-oxoG by extracts of cells from
the same patient (Dianov et al., 1999). However, the rate
of NTS repair in XP-G/CS cells was significantly lower
than normal. These observations parallel the require-
ment for XPG but not CSB for efficient removal of Tg
from either NTS or the genome overall (Cooper et al.,
1997).
Unrepaired 8-oxoG Is a Block to Transcription
One possible explanation for the inability of cells lacking
TCR to remove 8-oxoG when transcribed despite their
capacity for its repair in the absence of transcription is
that access of repair enzymes is prevented by a stalled
Figure 3. Map of the Shuttle Vectors Used and RT-PCR Analysis of
RNAP. The observation that RNAP stalled at a CPDTranscription of the 8-oxoG-Containing Sequence
prevents access of even the small repair enzyme pho-
(A) An 8-oxoG monomodified oligonucleotide corresponding to co-
tolyase to the lesion in vitro (Donahue et al., 1994) isdons 10±14 of human Ha-ras was inserted into the BglII site of
the original pS189 plasmid. Deletions of the SV40 replication origin
(pSDoriGO:C), of early SV40 promoter (pSDpearlyGO:C), and of late
promoter sequences (pSDoriDplateC:GO and pSDplateC:GO) are indi-
cated. In the nondeleted plasmid (pSGO:C), the 8-oxoG was located (B) Transcription of the sequence containing the 8-oxoG at 12 hr
in a transcribed sequence in the 39UTR of the TAg gene. Deletion after transfection of pSGO:C or pSDoriGO:C into normal diploid cells
of the early promoter eliminates transcription of TAg and of the is demonstrated by presence of a 270 bp RT-PCR product from
8-oxoG in pSDpearlyGO:C. In pSDoriDplateC:GO and pSDplateC:GO, the primers complementary to the 39 end of the TAg gene and to a
oligonucleotide containing the 8-oxoG was inserted on the opposite sequence downstream of the oligonucleotide carrying the lesion.
strand, and its transcription is eliminated by deletion of the late No product is detectable from pSDpearlyGO:C or pSDplateC:GO, veri-
promoter. Locations of RT-PCR products in (B) and in Figure 5D fying the elimination of transcription by deletion of the early or late
are indicated by small arcs within the plasmid. promoters, respectively. The left lane contains the size markers.
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consistent with this idea. To test it, we used RT-PCR to
compare transcription of the sequence containing the
8-oxoG in normal and XP-G/CS cells at 12 hr after trans-
fection. Transcription of an early region of TAg was com-
pared as a control. While both strains transcribed TAg
efficiently, only normal cells transcribed the 8-oxoG-
containing sequence (Figure 5D). No transcript that
spanned the lesion was detectable in XP-G/CS cells
despite the occurrence of active transcription upstream
of the lesion. Control experiments demonstrated that
this sequence is transcribed in these cells when it does
not contain a lesion. Similar results have been obtained
for two other normal diploid cell strains and for three
other TCR-defective mutants (data not shown). We con-
clude that unrepaired 8-oxoG is a block to transcrip-
tion in human cells. The predicted presence of stalled
RNAP at the lesion in cells defective in TCR provides a
likely explanation for the inability to remove it even by
global BER.
Discussion
The results presented here and previously establish that
two important oxidative lesions, Tg and 8-oxoG, are
removed in human cells by TCR that does not involve
NER but requires the XPB and XPD components of TFIIH
as well as XPG and CSB. Only certain mutations in XPD
and XPG, specifically those that give rise to clinical CS,
result in loss of TCR. Thus, examination of repair of
oxidative lesions has revealed that the functions of these
proteins in TCR are separable from their functions in
NER. TCR can therefore now be defined as a discrete
pathway for initiating rapid removal of lesions that block
Figure 4. Frequency of G to T Transversion Mutations at a Singletranscription rather than as a subpathway of NER as
8-oxoG in Normal and Repair-Defective Human Cell Lines
was originally believed.
The replicating vectors (Figure 3) were transfected into different
cell lines (Table 1) and cultured for 72 hr. Progeny plasmids were
Oxidative DNA Damage Blocks Transcription recovered and used to transform bacteria. The DNA sequence
around the location of the 8-oxoG was analyzed from plasmidsThe original model for strand-selective TCR (Mellon et
isolated from individual colonies.al., 1987) postulated that blockage of RNAP elongation
(A and B) The 8-oxoG lesion was present on a transcribed sequenceby a template lesion provides a signal for rapid recruit-
in pSGO:C. Mutation spectra are presented in Table 2.ment of repair. A corollary is that only lesions that block
(C) The 8-oxoG lesion was present on a nontranscribed sequence
RNAP will be subject to TCR. With a few exceptions, in pSDplateC:GO.
this relationship has generally held where examined
(Tornaletti and Hanawalt, 1999), but the effect of oxida-
tive damage on transcription has received little atten- human cells was inferred from the inhibition of activity
of purified hOGG1 on an 8-oxoG-containing oligonucle-tion, particularly for mammalian RNAP. In vitro studies
with prokaryotic RNAP have shown that Tg is a block otide in vitro by addition of whole cell extract (Hazra et
al., 1998).to elongation (Hatahet et al., 1994), consistent with its
removal by TCR in mammalian cells. In contrast, since
8-oxoG is readily copied by DNA polymerases, it would Multiple Functions of XPG and TFIIH
In contrast to CSB and TFIIH, XPG is not only requirednot be predicted to block transcription. Available evi-
dence is conflicting, with a fraction of template 8-oxoG for TCR but also contributes to efficient global repair of
8-oxoG, since XP-G/CS (class 3) cells with essentiallylesions causing termination for T7 RNAP (Hatahet et al.,
1994) but with elongation by E. coli RNAP in vitro not null mutations (Nouspikel et al., 1997) have slower than
normal lesion removal in NTS (Figure 5C). A similaraffected by 8-oxoG, although promoter clearance is re-
duced (Viswanathan and Doetsch, 1998). Nonetheless, involvement of XPG in efficient global removal of Tg
(Cooper et al., 1997) has been shown to be attributableit is quite clear from the studies reported here that
8-oxoG is a block to transcription in the mammalian cell to stimulation of hNth1 (Bessho, 1999; Klungland et al.,
1999a). Our results predict that XPG should also stimu-(Figure 5D) and that it is repaired preferentially in the
transcribed strand of an active gene (Figure 5C). One late 8-oxoG-DNA glycosylase, although this was not de-
tected for hOGG1 by Lindahl and coworkers. The possi-speculative possibility is that the block is not the lesion
per se but rather the lesion with protein bound to it. bility that a second human OGG activity (Hazra et al.,
1998) may be involved in TCR is intriguing and wouldIndeed, the existence of an 8-oxoG binding protein in
Transcription-Coupled Repair and CS
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Table 2. Analysis of Mutations in Plasmid pSGO:C after 72 hr Replication in Normal and Mutant Human Cell Lines
Characterization of Mutations
Number Number of Number of Number of Other Mutations,
of Clones Number of Mutants 8-oxoG ! T 8-oxoG ! D 8-oxoG ! A Untargeted*
Cell Line (Description) Analyzed (Frequency, %) (rel. freq., %) (rel. freq., %) (rel. freq., %) (rel. freq., %)
MRC5VI 274 3 (1.1) 3 (100) 0 0 0
XP12RO-SV (XP-A) 160 5 (3.1) 4 (80) 0 1 (20) 0
XP4PA-SV (XP-C) 223 6 (2.7) 5 (84) 1 (16) 0 0
XP14BR-SV (XP-C) 190 4 (2.1) 4 (100) 0 0 0
XP8CAC-SV (XP-C) 176 6 (3.4) 5 (83) 0 1 (17) 0
XP6BE-SV (XP-D) 244 5 (2) 5 (100) 0 0 0
XP125LO-SV (XP-G) 235 7 (3) 6 (85) 0 1 (15) 0
XP2BI-SV (XP-G class 2) 287 55 (19) 53 (96) 1 (2) 0 1 (2)
XP2BI-pBK2 (G418R) 272 45 (16) 42 (94) 0 1 (2) 2 (4)
XP2BI-pXPG1 (compl.) 300 3 (1) 3 (100) 0 0 0
XP3BR-SV (XP-G class 2) 295 58 (20) 56 (97) 1 (1.5) 1 (1.5) 0
XP3BR-pBK6 (G418R) 308 67 (22) 65 (97) 1 (1.5) 1 (1.5) 0
XP3BR-pXPG1 (compl.) 311 13 (4.5) 12 (86) 0 0 1 (14)
XP3BR-pXPG3 (compl.) 317 15 (4.7) 15 (100) 0 0 0
CS1AN-SV (CS-B) 195 72 (37) 68 (95) 2 (2.5) 2 (2.5) 0
XPCS2-SV (XP-D/CS) 201 61 (30) 60 (98) 0 0 1 (2)
XPCS1LV-SV (XP-G/CS) 215 88 (41) 85 (97) 0 2 (2) 1 (1)
XPCS2BA-SV (XP-B/CS) 194 68 (35) 64 (94) 2 (3) 1 (1.5) 1 (1.5)
* Mutations found by sequencing approximately 20 bp around the original 8-oxoG site and not targeted to this site.
be consistent with the observed mild phenotype of ho- a CPD in vitro (Selby et al., 1997). These results provide
evidence that TCR has two functions: (1) recruitment ofmozygous ogg1(2/2) null mice and the significant re-
moval of Fpg-sensitive lesions from their cells in culture appropriate repair proteins to lesions blocking transcrip-
tion, thus allowing them to be repaired more rapidly,in the absence of detectable OGG1 activity in vitro
(Klungland et al., 1999b). Moreover, while repair of and (2) perhaps more importantly, removal of the stalled
RNAP to allow repair to occur. Several different scenar-8-oxoG is undetectable in a nontranscribed sequence
in the ogg1(2/2) cells, removal is complete, although ios can be envisioned for this removal, but despite cur-
rent uncertainty as to the mechanism, the data presentedoccurring at a reduced rate when the same sequence
is transcribed (F. L., unpublished data). here suggest that repair of a transcription-blocking le-
sion is prevented unless the stalled RNAP is removedBoth the NER and TCR functions of XPG imply that
it may interact with TFIIH. Indeed, the corresponding by the TCR machinery. This function of TCR may provide
an explanation for the much greater UV sensitivity ofproteins Rad2 and TFIIH from budding yeast have been
isolated as a tight complex from a strain that overex- XP-D/CS compared to XP-D cells (Broughton et al.,
1995). As shown here, the former are defective in bothpresses Rad2 (Habraken et al., 1996), and two different
regions of XPG have been implicated in interactions with NER and TCR whereas the latter are defective in NER
only. Thus, RNAP blocked at unrepaired UV-inducedseveral components of human TFIIH (Iyer et al., 1996).
Direct demonstration of a requirement for interaction lesions would presumably be released in XP-D but not
XP-D/CS cells, which hence would suffer general tran-between XPG and TFIIH in either process awaits further
study, as does determination of whether the same or scription inhibition. This scenario is consistent with and
could explain the recently reported observations on dif-different interacting domains are involved. Our observa-
tion that certain XPD mutations inactivate NER without ferences between recovery of RNA synthesis after low
UV doses in these two types of cells (van Hoffen et al.,affecting TCR establishes that, as for XPG, the function
of TFIIH in TCR is separate from its role in NER. 1999).
BER and TCR of Oxidative Lesions in Human CellsDual Functions of Transcription-Coupled Repair
A complete block to 8-oxoG repair when the lesion is Figure 6 presents a model for repair of oxidative base
damage in human cells. The mechanism of TCR is ex-transcribed is observed in cells lacking functional TCR
machinery. We suggest that access of repair proteins pected to be much the same whether the actual repair
event is by BER as presumed for oxidative lesions, byto the lesion is prevented in that case, most likely by a
blocked RNAP. Results of a recent study of repair of UV NER for bulky lesions, or by some other repair process.
Lesions in TS are targeted for fastest repair by a signaldamage at nucleotide resolution in yeast support this
conclusion for the case of transcription-coupled NER generated by arrest of RNAP (Figure 6A). In order for
removal to proceed, the RNAP must be displaced to(Tijsterman and Brouwer, 1999). Since in our study no
repair was evident even after 3 days (Figure 5A), the allow access of repair enzymes. Since TCR occurs more
rapidly than global repair, the initiating repair enzymes,complex of RNAP with the lesion-containing DNA must
be very stable in the cell, in agreement with the reported presumably glycosylase/AP lyase for oxidative lesions,
may be actively recruited, although facilitated access20 hr half-life of the ternary complex of RNAP arrested at
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Figure 5. Kinetics of 8-oxoG Removal in Nor-
mal and Repair-Defective Human Cells and
Blockage of Transcription by the Lesion in
XP-G/CS Cells
(A±C) The nonreplicating shuttle vectors
pSDoriGO:C or pSDpearlyGO:C were trans-
fected into the indicated primary cell strains
and incubated for various times. Plasmid
DNA was recovered and used to transform
repair-defective bacteria. Plasmids from indi-
vidual bacterial colonies were analyzed for
the presence of G:C at the site of the original
lesion to indicate repair in the human cells.
Key to symbols for cell strains used is in (C).
(A) Removal of 8-oxoG in a transcribed se-
quence in normal (AS198), XP-G class 1
(XP125LO), XP-G class 2 (XP3BR; XP2BI), XP-
G/CS (XPCS1LV, class 3), and CS-B (CS1AN)
diploid cells. In several cases, values for cell
strains of similar repair capacity are so close
as to be indistinguishable, but these have
been displaced for clarity where results for
early times are replotted in (C).
(B) Removal of 8-oxoG in the same sequence
on the same strand as in (A) but in the ab-
sence of transcription due to deletion of the
early promoter in pSDpearlyGO:C.
(C) Detailed early kinetics of removal, replot-
ted on an expanded scale from data in (A)
and (B), indicated by the boxed areas. Over-
lapping symbols have been displaced slightly
along the X axis for clarity.
(D) RT-PCR analysis of samples collected at
12 hr after transfection of the nonreplicative
shuttle vector pSDoriGO:C into normal AS198
or XPG mutant XPCS1LV primary cells. Tran-
scription of the TAg gene is indicated by the
300 bp product from primers located near
the 59 end of the gene. Transcription of the
sequence containing the 8-oxoG is revealed
by the presence of a 270 bp product from
primers spanning the lesion as in Figure 3B.
A 3-fold excess of product was loaded in the
XP-G/CS case to emphasize the absence of
the 270 bp band. The left lane contains size
markers (M).
to the lesion is another possible mechanism. TCR rigor- proven, the repair process itself would be expected to
be identical to that in the genome overall for the sameously requires XPG, TFIIH, and CSB as shown here and
is aided by CSA (Leadon and Cooper, 1993). CSB is type of lesion, as indicated by the arrow from the right
pathway (Figure 6B, global BER) to the left. However, ifassociated with a fraction of RNAP II (van Gool et al.,
1997a) and thus may serve to recruit the other compo- this is true, the identity of the initiating glycosylase/AP
lyase for TCR of 8-oxoG is unclear and could be differentnents of the TCR machinery. In particular, several lines
of evidence including studies of repair at nucleotide from that for global repair. In addition to the factors
shown in Figure 6A, hMSH2 is also required for TCRresolution in both yeast (Tijsterman et al., 1997) and
human cells, (Tu et al., 1997) and in vitro studies with (Leadon and Avrutskaya, 1997), and still further complex-
ity is indicated by the recently identified requirement forpurified human proteins (Tantin, 1998) or yeast cell ex-
tracts (You et al., 1998), all support the idea that CSB the breast cancer±associated protein BRCA1 (Gowen
et al., 1998), although the role of either in this processrecruits TFIIH for TCR from its role in basal transcription
initiation. Whether XPG is also recruited directly by CSB is not yet understood.
Two rates are indicated in Figure 6B for global BERor indirectly because of its association with TFIIH is
not clear. Since removal of a lesion that has blocked of oxidative lesions, with the glycosylase/AP lyase step
being strongly stimulated by XPG. This presumably rep-transcription is prevented by defects in the TCR function
of either CSB, XPG, or TFIIH, all of these must be re- resents the pathway as it operates throughout most
of the genome in normal cells. Whether XPG mightquired for displacement of the arrested polymerase, al-
though their roles remain to be elucidated. The ensuing also influence subsequent steps is presently unknown.
Cleavage of the backbone by the AP lyase leaves a 59facilitated repair may depend specifically on XPG, since
it has roles in both global NER and BER. Although not phosphate but a blocked 39 terminus, requiring removal
Transcription-Coupled Repair and CS
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Cockayne Syndrome: A Transcription Disorder
Resulting from Defective Repair of Oxidative
DNA Damage
In large part due to the belief that TCR was a subpathway
of NER, alternatives to a repair defect as the underlying
cause of CS have been proposed. These have focused
on subtle defects in basal transcription because of the
essential role in transcription initiation of TFIIH, defects
in which can give rise to CS. However, most cases of
CS are due to defects in CSA or CSB, and although
there are indications that these proteins may play a
subtle role in maintaining efficiency of transcription (Ba-
lajee et al., 1997; Dianov et al., 1997), their involvement
cannot be rigorously required as there is no observable
effect on basal transcription by microinjection of block-
ing antibodies (van Gool et al., 1997a), and CSB knock-
out mice are viable (van der Horst et al., 1997). Further-
more, although approximately half of XP-G patients have
CS, there is no known involvement of XPG in basal
transcription. The results presented here provide a dif-
ferent explanation for the CS phenotype. Because muta-
tions in any of the five genes that result in CS all affect
TCR of oxidative damage, it is likely that this molecular
defect underlies the clinical phenotype.
Oxidative stress in brain is believed to be relatively
high, presumably giving rise to a constant high flux of
oxidative DNA damage. Its accelerated repair in tem-
plate strands presumably is important for maintaining
transcription of genes essential for cellular activity and
neurological function. However, in CS cells, not only
is TCR missing but lesions in transcribed strands are
inaccessible even to global repair. Thus, oxidative le-
sions will accumulate, posing blocks to transcription.
Depletion of mRNA, and hence of protein synthesis, due
to irreversible sequestering of the transcription machin-
ery at unrepaired lesions could account for both theFigure 6. Model for Repair of Oxidative Lesions in Human Cells
neurological deterioration and general wasting that are
The steps in the reaction and the proteins assumed to be responsible
characteristic of the syndrome. Trapped transcription asfor each are indicated.
a consequence of defective TCR of endogenous lesions(A) The left pathway shows the preferential repair of oxidative lesions
has previously been suggested as the molecular basisin transcribed strands as described in the text. The repair steps
following displacement of the stalled RNA polymerase II (RNAP) are for CS (Hanawalt, 1994; Nouspikel et al., 1997; van Gool
presumed to be identical to those shown on the right, as indicated et al., 1997b; de Laat et al., 1999). The results presented
by the arrow. here provide experimental evidence for this idea as well
(B) The right pathway shows the repair of lesions in nontranscribed as establishing the key roles of XPG and TFIIH. Interest-
strands or inactive areas of the genome. Two rates are indicated
ingly, some XP-A patients also exhibit progressive neu-for the glycosylase step, with the heavy arrow indicating faster gly-
rological abnormalities, although their ability to repaircosylase action in the presence of XPG.
8-oxoG and Tg is normal. However, the numerous clini-
cal differences that exist between XP and CS patients
of the 39 terminal sugar phosphate by APE to generate suggest a different origin of the abnormalities in the two
a primer for DNA polymerase. Two pathways for the syndromes. Inability to repair a minor class of oxidative
resynthesis step of BER have been identified: a short lesions may account for the gradual neurological degen-
patch pathway involving a single nucleotide insertion eration in some XP patients (Satoh et al., 1993; Reardon
by DNA polymerase b, and a longer patch pathway re- et al., 1997), whereas inability to repair a much more
quiring PCNA and the flap endonuclease FEN-1 (Klung- frequent class of transcription-blocking lesions is pro-
land and Lindahl, 1997) that predominantly involves DNA posed to underlie the early developmental failure char-
polymerase d or e (Fortini et al., 1998; Stucki et al., 1998). acteristic of CS. Finally, reduced repair efficiency for
Available evidence from in vitro studies suggests that oxidative lesions throughout the genome in addition to
the short patch pathway may be the primary one for the loss of TCR could contribute to the extreme severity
BER of oxidative lesions (Fortini et al., 1999), although of the syndrome in XP-G/CS patients with mutations
the mechanism of the resynthesis step in TCR remains that lead to loss of XPG (Nouspikel et al., 1997).
an open question. Both Ligase I and the Ligase III- We conclude that TCR of oxidative lesions is a major
XRCC1 complex have been implicated in the final step repair pathway required to ensure low cellular toxicity
and low mutation rates in the face of oxidative stress.of BER, and it is not known which participates in TCR.
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a single-stranded (ss), modified pS189 DNA carrying a C (pS189This pathway is evidently of particular importance for
[C]) in the position opposite the lesion was constructed by insertingnormal neurological development and function in humans.
a complementary 19-mer oligonucleotide into pS189. The active
M13 phage replication origin in pS189 allowed production of ss DNA
Experimental Procedures using M13 K07 helper phage (Pharmacia). A gapped ds plasmid
was constructed by hybridizing ss plasmid pS189(C) with ds pS189
Cell Lines and Culture Conditions linearized at the BglII site. Twenty micrograms of gapped duplex
The cell lines used are described in Table 1. They were cultured plasmid DNA thus formed was hybridized with 5 mg of 59-32P phos-
either in Dulbecco's modified Eagle's medium (shuttle vector experi- phorylated 8-oxoG oligonucleotide, ligated with T4 DNA ligase (Bio-
ments) or in McCoy's 5A medium (cellular repair experiments) with labs, UK), and covalently closed molecules purified by isopycnic
10% fetal calf serum, 2 mM glutamine, and antibiotic/antimycotic centrifugation with ethidium bromide. For nonreplicating shuttle
solution. The XP14BR-SV cell line was maintained in medium con- vectors, pS189 deleted at the SV40 replication origin (pSDSVori)
taining G418. was constructed as previously described (Le Page et al., 1998) and
For use in mutagenesis experiments, XPCS1LV, XP125LO, and used to construct the monomodified plasmid DNA by the same
XP-CS-2 diploid fibroblasts were transformed by the pLAS-wt plas- protocol.
mid carrying the TAg of SV40 (Daya-Grosjean et al., 1987). To obtain Plasmid deleted of its early region promoter (pSDpearly) was con-XP-G mutant cell lines complemented by expression of wild-type structed by digesting ss pS189 DNA with HaeIII and PvuII after
XPG, normal VA13 and XP-G mutant SV40-transformed fibroblasts hybridization of oligonucleotides at the restriction sites. The oligonu-
XP2BI-SV and XP3BR-SV (Klein et al., 1990) were transfected by cleotides were removed by heating, followed by filtration through
electroporation with a pBK-CMV phagemid vector (Stratagene) or a Spun size S-400 column (Pharmacia, Saclay, France). The long
with the vector containing the wild-type XPG cDNA subcloned from restriction fragment was gel-purified (Nucleotrap Purification kit,
the EBO-pLPP-hRAD2 vector (Scherly et al., 1993). Their construc- Clontech) and recircularized with T4 DNA ligase to produce
tion, selection, and characterization with respect to repair of UV pS189DpearlyGO:C in which a 285 bp segment of pS189 containingand oxidative lesions in the cellular genome are to be described both the early promoter and the SV40 origin is deleted (Figure 3).
elsewhere. Plasmid deleted of late promoter sequences (pSDplate or
pSDoriDplate) was obtained by a two-step protocol, first by digestion
Assays for Repair of Oxidative Damage in the Cellular Genome of ss plasmid, either pS189 or pSDSVori, with SphI and Fnu4HI
Measurements of TCR of X-ray damage were performed as de- after hybridization of oligonucleotides at the restriction sites, their
scribed previously (Leadon and Cooper, 1993) using an immunologi- removal by heating and filtration through a Spun size S-400 column,
cal assay that detects incorporation of bromodeoxyuridine (BrdUrd) and gel purification of the long fragment. The resulting ss plasmid
in repair patches. In brief, cells uniformly labeled with 3H-thymidine deleted of 25 bp was digested by BamHI and BstNI in the same
were irradiated with 10 Gy of X-rays and either harvested immedi- way and recircularized using T4 DNA ligase to produce ds plasmid
ately or allowed to repair in medium containing BrdUrd. Purified DNA deleted by 90 bp. The SphI-Fnu4HI fragment corresponds to
DNA was digested with EcoRI, heat denatured, and reacted with a the sequence necessary for TAg-mediated transcriptional activation
monoclonal antibody against BrdUrd. Total repair was assessed by of the late promoter (Gilinger and Alwine, 1993), and the BamHI-
the amount of 3H-labeled DNA bound. Equal amounts of DNA from BstNI fragment corresponds to a cluster of initiator-like elements.
the supernatant (free DNA) and pellet (antibody-bound) were elec- In order to allow early transcription to be active, albeit delayed, the
trophoresed on neutral agarose gels and transferred to a membrane, extent of deletion in the promoter region was limited to the minimum
which was hybridized with RNA probes for either strand of the hu- necessary.
man metallothionein (MT) gene family. The value for intensity of
hybridization was multiplied by the proportion of DNA in the bound
or free fractions to obtain the total amount of the strand of interest Assay for Mutagenesis of GO-Containing Plasmids Replicated
in each fraction. The percentage of each strand bound by the anti- in Human Cells
body was then calculated from the total amount of the strand in the Eight hundred nanograms of closed circular ds plasmid was trans-
bound fraction divided by the total amount in the bound plus free fected into semiconfluent cultures in 10 cm2 dishes using the cat-
fractions. Results are presented for the MTIA gene, which is located ionic liposome Dotap (Boehringer). Cells were incubated for 72 hr
on a 10 kb EcoRI restriction fragment and is transcribed at basal and collected, and plasmid DNA was recovered by a small-scale
levels in all cell lines and tissues examined. alkaline lysis method (Stary et al., 1992). Digestion with BglII elimi-
To assay for TCR of Tg, cells labeled as above were treated with nated any progeny molecules arising from replication of DNA that
10 mM hydrogen peroxide for 15 min at 378C in culture medium. escaped the initial BglII digestion during construction. Digestion
These conditions induce approximately 1 Tg per 10 kb (Cooper et with DpnI eliminated any molecules not replicated in the human
al., 1997). After removal of the peroxide-containing medium, cells cells.
were washed and lysed immediately or allowed to repair. Repair of Recovered plasmid DNA was used to transform DH5a bacteria
Tg in either strand of the MTIA gene was determined with RNA by electroporation and transformants were selected by ampicillin
probes as described for BrUra-containing repair patches but using resistance. As judged by the similar number of colonies obtained,
a monoclonal antibody to Tg as previously described (Leadon and replication of the plasmid was approximately equal in all human cell
Lawrence, 1992). The fraction of the fragments containing Tg (bound lines. DNA from individual bacterial colonies was prepared using
by the antibody) immediately after treatment was set at 100%. DNA the Jetsar genome miniplasmid purification system (Bioprobe). The
from X irradiated cells was analyzed for global removal of Tg using frequency and spectrum of mutations were determined using NgoMI
a monoclonal antibody that recognizes Tg in DNA in an enzyme- digestion, which cleaves only when the G:C base pair is present at
linked immunosorbent assay (ELISA; Leadon, 1988). 10 Gy of X-rays the site of the original GO in its recognition sequence (GCCGGC).
induced approximately 1 Tg per 106 bases as previously reported NgoMI-resistant plasmids were sequenced using the Sequenase
(Cooper et al., 1997; Le Page et al., 1998). 2.0 kit (Amersham). Three independent transformations were carried
out for each experiment, and mutation frequencies were determined
Construction of Closed Circular Plasmids Carrying a Unique in each case from more than 100 clones.
GO:C Pair
The pS189 shuttle vector used for construction of 8-oxoG plasmids
was a gift from M. Seidman. The inserted 19-mer 8-oxoG oligonucle- Assay for Removal of GO from Plasmid DNA in Human Cells
For repair studies, nonreplicating plasmids deleted at the SV40 repli-otide contained a fragment of the human Ha-ras gene from codons
10±14 with the lesion on the second guanine of codon 12 (59-GATCG cation origin were used as previously described (Le Page et al.,
1998). Transfection was performed as for the mutagenesis assays,GCGCCGGOCGGTGTG-39). It was produced as described pre-
viously (Bodepudi et al., 1992). but primary cells without TAg were used and plasmid DNA was
recovered after incubation from 2±72 hr. Elimination of any contami-The replicative plasmid containing a unique GO:C (Figure 3) was
constructed as described previously (Le Page et al., 1998). In brief, nating extracellular input DNA was performed by treatment of cell
Transcription-Coupled Repair and CS
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cultures with DnaseI prior to extraction. Recovered plasmid mole- References
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